m-AMSA and PALA: Two new agents in cancer chemotherapy
- 1 November 1979
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 3 (3), 135-141
- https://doi.org/10.1007/bf00262414
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Anthracycline derivatives in new drug development programs.1979
- Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.1978
- EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTATE ON MURINE TUMORS AND NORMAL TISSUES INVIVO AND INVITRO AND RELATIONSHIP OF SENSITIVITY TO RATE OF PROLIFERATION AND LEVEL OF ASPARTATE-TRANSCARBAMYLASE1978
- INDUCTION OF LIMITED DNA DAMAGE BY ANTI-TUMOR AGENT CAIN ACRIDINE1978
- Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents.1977
- PHARMACOLOGIC DISPOSITION OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE IN MICE AND RATS1977
- Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-aspartate in vivoBiochemical Pharmacology, 1977
- Inhibition by N-(Phosphonacetyl)-l-Aspartate of Aspartate Transcarbamylase Activity and Drug-induced Cell Proliferation in MiceJournal of Biological Chemistry, 1974
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesEuropean Journal of Cancer (1965), 1974
- An assessment of the immunosuppressive activity of the anti-tumour compound 4′-[(9-acridinyl)amino]methanesulphon-m-anisidide (m-AMSA)European Journal of Cancer (1965), 1974